JONATHAN FLANAGAN to Humans
This is a "connection" page, showing publications JONATHAN FLANAGAN has written about Humans.
Connection Strength
0.138
-
Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia. PLoS One. 2014; 9(10):e110740.
Score: 0.010
-
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013 Apr 18; 121(16):3237-45.
Score: 0.008
-
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia. Br J Haematol. 2012 Apr; 157(2):240-8.
Score: 0.008
-
Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
Score: 0.007
-
Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia. Mutat Res. 2010 Apr 30; 698(1-2):38-42.
Score: 0.007
-
Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia. Am J Hematol. 2009 Jun; 84(6):328-34.
Score: 0.007
-
The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum Genet. 2006 Nov; 120(4):581-8.
Score: 0.005
-
The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol. 2006 Jul; 134(2):233-7.
Score: 0.005
-
The genetic basis of human erythrocyte pyridoxal kinase activity variation. Haematologica. 2006 Jun; 91(6):801-4.
Score: 0.005
-
Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. Br J Haematol. 2006 Feb; 132(4):523-9.
Score: 0.005
-
Soluble transferrin receptor-1 levels in mice do not affect iron absorption. Acta Haematol. 2006; 116(4):249-54.
Score: 0.005
-
Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Blood Adv. 2024 11 12; 8(21):5529-5538.
Score: 0.005
-
Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia. Sci Adv. 2024 Aug 02; 10(31):eadj3145.
Score: 0.005
-
Identification of sequence variation in the galactose-1-phosphate uridyl transferase gene by dHPLC. Mol Genet Metab. 2004 Feb; 81(2):133-6.
Score: 0.005
-
Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci. Br J Haematol. 2023 04; 201(2):343-352.
Score: 0.004
-
Vascular Transcriptomics: Investigating Endothelial Activation and Vascular Dysfunction Using Blood Outgrowth Endothelial Cells, Organ-Chips, and RNA Sequencing. Curr Protoc. 2022 Oct; 2(10):e582.
Score: 0.004
-
The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions. Transl Res. 2023 02; 252:34-44.
Score: 0.004
-
Noncanonical Roles of Caspase-4 and Caspase-5 in Heme-Driven IL-1? Release and Cell Death. J Immunol. 2021 04 15; 206(8):1878-1889.
Score: 0.004
-
Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic immune dysregulation. Eur J Haematol. 2021 Jun; 106(6):783-787.
Score: 0.004
-
A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data. Blood Adv. 2020 09 22; 4(18):4347-4357.
Score: 0.004
-
Genetic variants in toll-like receptor 4 are associated with lack of steroid-responsiveness in pediatric ITP patients. Am J Hematol. 2020 04; 95(4):395-400.
Score: 0.003
-
Organ-on-chips made of blood: endothelial progenitor cells from blood reconstitute vascular thromboinflammation in vessel-chips. Lab Chip. 2019 07 23; 19(15):2500-2511.
Score: 0.003
-
Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition. Transfusion. 2018 03; 58(3):726-735.
Score: 0.003
-
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil. Blood Cells Mol Dis. 2016 11; 62:32-37.
Score: 0.003
-
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia. PLoS One. 2016; 11(10):e0164364.
Score: 0.003
-
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol. 2013 Jul; 88(7):571-6.
Score: 0.002
-
Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial. Pediatr Blood Cancer. 2012 Aug; 59(2):254-7.
Score: 0.002
-
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood. 2011 Nov 03; 118(18):4985-91.
Score: 0.002
-
Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure. Br J Haematol. 2011 Jul; 154(1):134-40.
Score: 0.002
-
Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol Cell. 2009 Sep 24; 35(6):830-40.
Score: 0.002
-
The distal location of the iron responsive region of the hepcidin promoter. Blood. 2007 Nov 01; 110(9):3436-7.
Score: 0.001
-
Frequency distribution of the Los Angeles and Duarte galactose-1-phosphate uridyltransferase variant alleles in the Irish population. Mol Genet Metab. 2004 Aug; 82(4):345-7.
Score: 0.001